MAM
SAGE

Monaco Asset Management’s Sage Therapeutics SAGE Stock Holding History

Monaco Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-366,619
Closed -$3.34M – 106
2025
Q2 		$3.34M Sell
366,619
-75,000
-17% -$552K 0.59% 31
2025
Q1 		$3.51M Buy
+441,619
New +$3.23M 0.72% 20

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Monaco Asset Management's SAGE Position: Q3 2025 in Review

Monaco Asset Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 366,619 shares — an estimated $3.34M sold.

Monaco Asset Management first reported a position in SAGE in Q1 2025 and held it in 2 quarters. The position peaked at $3.51M in Q1 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Monaco Asset Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Monaco Asset Management sold 366,619 Sage Therapeutics shares in Q3 2025, an estimated $3.34M.
  • Monaco Asset Management first reported a position in Sage Therapeutics in Q1 2025 and held it in 2 quarters.
  • Monaco Asset Management's Sage Therapeutics position peaked at $3.51M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Monaco Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.